Clarithromycin (Compound)

Synonyms:clarithromycin, 81103-11-9, Biaxin, 6-O-Methylerythromycin, Klaricid, 6-O-Methylerythromycin a, Abbott-56268, Clarithromycine, Clathromycin, Macladin, Klacid, Veclam, Erythromycin, 6-O-methyl-, Mavid, Naxy, A-56268, TE-031, Clarith, Cyllind, Kofron, Zeclar, Clarithromycinum, Clarithromycin identity, Biaxin XL, TE031, NSC-758704, CHEBI:3732, H1250JIK0A, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, DTXSID3022829, Claritromicina, Abbotic, Astromen, Bicrolid, Clacine, Clambiotic, Claribid, Claricide, Claridar, Claripen, Fromilid, Heliclar, Klaciped, Mabicrol, Clacee, Clacid, Clarem, Crixan, Cyllid, Klabax, Klarid, Klarin, Maclar, Helas, Adel, Biaxin filmtab, Klax, Biaxin HP, Biaxin xl filmtab, Klaricid Pediatric, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, Clarithromycin extended release, DTXCID40820062, DRG-0099, Klaricid H.P., CTY, SMR000466382, Clarithromycine [INN-French], Clarithromycinum [INN-Latin], Claritromicina [INN-Spanish], CAS-81103-11-9, SR-05000001992, clarithromycina, UNII-H1250JIK0A, Clarosip, CCRIS 8833, Klaricid XL, HSDB 8055, (14R)-14-Hydroxyclarithromycin, NCGC00095117-01, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy, Clarithromycin,(S), Biaxin (TN), Spectrum_000089, CPD000466382, Clarithromycin [USAN:USP:INN:BAN:JAN], SpecPlus_000559, 6-O-methyl erythromycin, O(6)-methylerythromycin, Spectrum2_001668, Spectrum3_001667, Spectrum4_000629, Spectrum5_001729, 6-0-methylerythromycin A, A56268, CLARITHROMYCIN [MI], CHEMBL1741, CLARITHROMYCIN [INN], CLARITHROMYCIN [JAN], SCHEMBL38125, BSPBio_003453, KBioGR_001218, KBioSS_000509, MLS000759516, MLS001201751, MLS001424066, BIDD:GT0200, CLARITHROMYCIN [VANDF], DivK1c_006655, SPECTRUM1504231, SPBio_001855, CLARITHROMYCIN [MART.], Lactoferrin B & Clarithromycin, Lactoferrin H & Clarithromycin, CLARITHROMYCIN [USP-RS], CLARITHROMYCIN [WHO-DD], Clarithromycin (Biaxin, Klacid), Clarithromycin & Interleukin-12, CLM & IL-12, GTPL10903, KBio1_001599, KBio2_000509, KBio2_003077, KBio2_005645, KBio3_002673, ANX-015, SDP-015, Clarithromycin (JP17/USP/INN), Clarithromycin, >=95% (HPLC), Clarithromycin, >=98% (HPLC), HMS1922H09, HMS2051G18, HMS2090O11, HMS2094M05, HMS2231A08, HMS3715J17, Pharmakon1600-01504231, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dion, CLARITHROMYCIN [ORANGE BOOK], Tox21_111429, Tox21_202903, BDBM50404044, CCG-39086, CLARITHROMYCIN [EP MONOGRAPH], CLARITHROMYCIN [USP IMPURITY], LMPK04000014, NSC758704, s2555, CLARITHROMYCIN [USP MONOGRAPH], AKOS015894242, PREVPAC COMPONENT CLARITHROMYCIN, CS-2576, DB01211, NC00140, NSC 758704, CLARITHROMYCIN IDENTITY [USP-RS], NCGC00178054-01, NCGC00178054-06, NCGC00260449-01, CLARITHROMYCIN COMPONENT OF PREVPAC, HY-17508, SBI-0206716.P001, C2220, Clarithromycin 100 microg/mL in Acetonitrile, C06912, D00276, F14975, AB00053394-10, AB00053394-12, AB00053394-13, AB00053394_14, AB00053394_15, A840042, Q118551, Q-200870, SR-05000001992-1, SR-05000001992-2, BRD-K49668410-001-07-1, BRD-K49668410-001-18-8, Z1515385076, Clarithromycin, European Pharmacopoeia (EP) Reference Standard, Clarithromycin, United States Pharmacopeia (USP) Reference Standard, Clarithromycin Identity, United States Pharmacopeia (USP) Reference Standard, Clarithromycin for peak identification, European Pharmacopoeia (EP) Reference Standard, Clarithromycin, Pharmaceutical Secondary Standard; Certified Reference Material, (3R,4S,5R,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4R,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacy, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-14-ethyl-12,13-dihydroxy-4-((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yloxy)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11S, 12R,13S,14S)-6-{[(2S,3R,4S,6R)- 4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-12,13-dihydroxy- 4-{[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-4,6- dimethyloxan-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexamethyl-1- oxacyclotetradecane-2,10-dione
Pubchem:PUBCHEM:84029
Id:04c94473-ba7d-53be-a512-8bfc65a632ba
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Clarithromycin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Clarithromycin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Clarithromycin.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.